Cargando…

microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index

Background: Despite several authors who have hypothesized that alterations of small noncoding RNAs (miR) are implicated in the etiopathogenesis of polycystic ovarian syndrome (PCOS), contrasting findings have been reported so far. Discrepancies in body mass index (BMI) levels may account for these d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butler, Alexandra E., Ramachandran, Vimal, Sathyapalan, Thozhukat, David, Rhiannon, Gooderham, Nigel J., Benurwar, Manasi, Dargham, Soha R., Hayat, Shahina, Hani Najafi-Shoushtari, S., Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199502/ https://www.ncbi.nlm.nih.gov/pubmed/32411089 http://dx.doi.org/10.3389/fendo.2020.00206

Ejemplares similares

Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
por: Butler, Alexandra E., et al.
Publicado: (2020)

Expression of microRNA in follicular fluid in women with and without PCOS
por: Butler, Alexandra E., et al.
Publicado: (2019)

Changes in Blood microRNA Expression and Early Metabolic Responsiveness 21 Days Following Bariatric Surgery
por: Atkin, Stephen L., et al.
Publicado: (2019)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
por: Butler, Alexandra E., et al.
Publicado: (2020)

Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
por: Al-Hail, Noora, et al.
Publicado: (2019)

Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

Association of microRNAs With Embryo Development and Fertilization in Women Undergoing Subfertility Treatments: A Pilot Study
por: Butler, Alexandra E., et al.
Publicado: (2021)

Corrigendum: Association of microRNAs With Embryo Development and Fertilization in Women Undergoing Subfertility Treatments: A Pilot Study
por: Butler, Alexandra E., et al.
Publicado: (2022)

Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T(3) in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

SAT366 Expression of Amyloid-related Proteins Associated With Dementia in Polycystic Ovary Syndrome Compared to a Control Population
por: Butler, Alexandra E, et al.
Publicado: (2023)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Bariatric Surgery Modulates Urinary Levels of MicroRNAs Involved in the Regulation of Renal Function
por: Alkandari, Abdullah, et al.
Publicado: (2019)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Association of Vitamin D Metabolites With Embryo Development and Fertilization in Women With and Without PCOS Undergoing Subfertility Treatment
por: Cunningham, Thomas Keith, et al.
Publicado: (2019)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

SAT446 Association of Polychlorinated Biphenyls With the Hormonal Parameters of the Normal Menstrual Cycle May Contribute to Unexplained Infertility
por: Butler, Alexandra E, et al.
Publicado: (2023)

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2019)

Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone Deficiency
por: Gonzalez, Susana, et al.
Publicado: (2018)

The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
por: Konya, Judit, et al.
Publicado: (2019)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Effect of Soy Isoflavones on Steroid Metabolism
por: Swart, Amanda C., et al.
Publicado: (2019)

Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D
por: Nandakumar, Manjula, et al.
Publicado: (2023)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4kaonaom4qm93stisd0m87035